Cook Regentec's Advance CS Coronary Sinus Infusion Catheter Used to Deliver Therapeutic Agent for Heart Failure
July 23, 2018—Cook Regentec announced the first clinical use in the United States of its Advance CS coronary sinus infusion catheter and Compass CT disposable pressure transducer to deliver a therapeutic in heart failure patients.
According to the company, the Advance CS device is a percutaneous balloon infusion catheter designed for use in retrograde coronary sinus infusion procedures. It is intended for temporary occlusion of the coronary sinus for infusion of contrast media, drugs, and therapeutic agents, or possible introduction of devices into the coronary venous system.
The disposable Compass CT provides continuous monitoring of infusion pressure and pressure in the patient's heart during the procedure. It features an integrated digital display that monitors physiological pressure and displays pressure during the infusion of therapeutic agents.
The first United States clinical use of the Cook devices was proctored by Amit N. Patel, MD, who is Chief of Cardiac Surgery at the University of Miami Health System in Miami, Florida.
In Cook's press release, Dr. Patel commented, "Using the Advance CS coronary sinus infusion catheter, clinicians can deliver therapeutics, including cell and gene therapies, in an outpatient setting. What we once performed on patients through invasive surgery can now be done in a minimally invasive procedure, lowering medical costs, increasing patient safety and delivering the most effective biologics to treat each patient. In the evolution of gene and cell therapies, this is a revolutionary medical device for both clinicians and patients."